Scoop turns study, manufacturing, and clinical data into living regulatory submissions: every sentence traced to its source, checked for conflicts, and kept current as the science changes.
Founders · Product
- Founded
- 2025
- Team
- 2 people
Browser storage is unavailable. Keep this page open and export your collection before leaving.
Explore
34 businesses
Sourced product detail plus founders, customers, workflow, pricing, origins or business model.
FinalDose is building a programmable, DNA-targeted therapeutic platform to eliminate cancer at its genetic root — one chassis, retargeted in days across the long tail of driver mutations.
Founders · Product
- Founded
- 2025
- Team
- 5 people
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy…
Founders · Product
- Founded
- 2024
- Team
- 2 people
Rhizome AI is a regulatory intelligence tool for life sciences. Cited answers from FDA, EMA and 15 other health authorities.
Founders · Product
- Founded
- 2025
- Team
- 1 people
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology.
Founders · Product
- Founded
- 2025
- Team
- 3 people
Eva catches the studies your reviewers miss. 97.2% screening sensitivity, validated on 30,000+ documents. AI-powered SLR in 48 hours for pharma, CROs, and researchers.
Founders · Product
- Founded
- 2024
- Team
- 1 people
Delineate creates models from the totality of available evidence — in any therapeutic area — so development, regulatory, and commercial teams act on quantitative evidence in a fraction of the time.
Founders · Product
- Founded
- 2024
- Team
- 20 people
Cancer immunotherapy that turns cancer cells into biofactories minting their own destruction.
Founders · Product
- Founded
- 2024
- Team
- 2 people
Ligo Biosciences builds generative models and experimental systems for enzyme design.
Founders · Product
- Founded
- 2024
- Team
- 4 people
Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver…
Founders · Product
- Founded
- 2024
- Team
- 8 people